Daily Tech: Amazon Nova Act, Google AI in drugs, Humanoid robotics, BABA grows

FutureGate | April 01 2025

Amazon Introduces Nova Act, an AI-Powered Web Agent

Amazon has unveiled Nova Act, an advanced AI-powered agent designed to navigate and control web browsers autonomously. This marks a significant step in Amazon’s broader AI ambitions, as the company looks to integrate automation into e-commerce, customer service, and enterprise applications. The AI agent could revolutionize how businesses and consumers interact with online platforms, enhancing efficiency and decision-making.

Google’s Isomorphic Labs Secures $600M for AI-Driven Drug Discovery

Google’s AI drug research firm, Isomorphic Labs, has raised $600 million in funding to accelerate the development of AI-powered drug discovery. The company aims to leverage cutting-edge machine learning models to streamline pharmaceutical research, reducing the time and cost of developing new medicines. The investment highlights growing confidence in AI’s role in reshaping the healthcare and biotech industries.

Figure AI, Backed by Jeff Bezos, Takes on Tesla in Humanoid Robotics

Figure AI, a robotics startup backed by Jeff Bezos, is emerging as a key competitor to Tesla’s Optimus in the race to commercialize humanoid robots. The company’s latest advancements in AI-driven robotics aim to automate industrial labor, logistics, and manufacturing. With high-profile investors and cutting-edge technology, Figure AI is positioning itself as a major player in the growing market for intelligent humanoid robots.

Alibaba Reports 27% Surge in U.S. SME Orders

Alibaba.com has reported a 27% increase in orders from U.S. small and medium-sized enterprises (SMEs) during its March 2025 Expo. The growth highlights rising demand for Chinese manufacturing among American businesses, despite ongoing U.S.-China trade tensions. Alibaba’s expansion into global B2B e-commerce continues to strengthen its position as a key supplier for businesses seeking cost-efficient production and supply chain solutions.